Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-26-333914
Filing Date
2026-08-05
Accepted
2026-08-05 08:06:10
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5177
  Complete submission text file 0001193125-26-333914.txt   6649
Mailing Address C/O PURETECH HEALTH LLC 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address
Zohar Daphne (Filed by) CIK: 0001727388 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Subject) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95656 | Film No.: 261241415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)